The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

ConditionAlpha-1 Antitrypsin Deficiency

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorUniversity of Florida

About this trial

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

Eligibility criteria

Qualifiers

Individuals of any age at risk for alpha-1 antitrypsin deficiency on the basis of symptoms or family genetic risk.

Disqualifiers

Any person who has already had genotype and AAT level testing completed and has a qualified result.

Trial design

Treatments tested in this trial

Alpha-1 Antitrypsin Genotype

Treatment groups

No treatment groups listed

Sponsors and collaborators

University of Florida

Lead sponsor

Source ClinicalTrials.gov